Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC

NCT04211090 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small-cell Lung Cancer
Brain Metastases

Interventions

DRUG: Camrelizumab
DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Sun Yat-sen University

Collaborators

[object Object]